Check building materials and
spaces for visible mold
Assess moisture – water
leaks, high humidity, and/or condensation
Consider occupant complaints
Check for HVAC system
involvement, condensate pans, air pathways, and mold on or around air
diffuser
In cases of health concerns,
litigation or when the source of contamination is unclear, sampling
should be considered as part of the building evaluation
Sampling may not be
necessary, if visible mold is present, it should be remediated by a
qualified contractor.
If mold is present but not
visually detectable, sampling may reveal evidence of mold
amplification or reservoirs indoors
Air sampling can indicate
whether the mix of molds is typical or atypical, or unusual in
concentration
Using a certified industrial
hygienist and an accredited lab is essential, and the sampling should
be done in an effort to answer a specific question about the building
Not all health effects are
controversial. Fungal infections and allergies are well known.
These effects can be measured and reproducibly demonstrated.
The clinical relevance of
mycotoxin exposure under realistic exposure levels is not fully
established.
Current supporting evidence
is based on case studies rather than controlled studies.
The studies that have been
done have not yet been reproduced and some of the symptoms are
subjective and difficult to quantify.
The controversy is
intensified since the health effects attributed to mycotoxins are
often serious and sometimes claimed to be permanent.
In summary, mold growth in the built
environment should be considered unacceptable from the perspectives of
health effects and building performance.
Why are there no standards for mold
exposure?
Health hazards of exposure to environmental molds relate to four broad
categories of chemical/biological attributes of molds and their
metabolites.
Classified as: 1) irritants,
2) allergens, 3) toxins, and rarely
4) pathogens. Different mold species may be more or less hazardous
with respect to any and all of these categories.
Risks from exposure to a
particular mold species may vary depending on a number of factors,
primarily, each individual’s sensitivity can be widely different. As
an example, if you are allergic to penicillin, you are allergic to
mold.
Exposure standards may not
ever be established, and it is uncertain which governmental agency may
do so.
With no standards, how do I interpret
my sampling results?
Comparing the kinds and
levels of organisms detected in different environments is a useful
method.
Usual comparisons are indoor
to outdoor, and complaint areas to non-complaint areas. In buildings
without mold problems the qualitative diversity of airborne fungi
indoors and outdoors should be similar.
Some fungi, when found over
and above background levels, are strong indicators for a moisture
problem with a building related source that should be addressed.
Does mold remediation always require isolation/ containment?
Yes, mold remediation should
always require some level of isolation of materials or containment.
Local area or full
containment decisions can be made based on the potential for occupant
exposure or building contamination.
The decisions should NOT be
made based on the SIZE of the affected area. There can be one million
mold spores in a one square inch area of affected porous material. It
is the dispersion of these spores that needs to be controlled
(contained).
Are biocides required or useful in remediation projects?
In most remediations
biocides are not a substitute for the removal of the affected building
materials.
Mold spores have metabolites
present that are secreted into the materials upon which mold has
grown. The application of biocides may kill mold spores, but it does
not necessarily eliminate these metabolites.
Treating an active mold
growth site with the above mentioned spore density (one million spores
in a square inch) with a biocide that has effectiveness of 99.999%
would leave an estimated 10 viable spores per square inch. If the
underlying moisture problem is not resolved, mold growth may re-occur.
What are the gaps in our knowledge about mold exposure and the
health effects of mold exposure?
Chief among our knowledge
gaps are (1) defining how mycotoxins affect human health and (2) the
health risks associated with mycotoxin, microbial volatile organic
compound, allergen, and glucan exposures, particularly the proposed
response to Stachybotrys mycotoxins associated with hemosiderosis.
Until microbiological
methods for demonstrating mold concentrations in the environment are
standardized, epidemiological studies necessary to determine dose-
response can only suggest association, not cause and effect.